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Abstract
Objective. To investigate the effect of a primary care model for COPD on process of care and patient outcome. Design.
Controlled study with delayed intervention in control group. Setting. The GP delegates tasks to a COPD support service
(CSS) and a practice nurse. The CSS offers logistic support to the practice through a patient register and recall system for
annual history-taking and lung function measurement. It also forms the link with the chest physician for diagnostic and
therapeutic advice. The practice nurse’s most important tasks are education and counselling. Subjects. A total of 44 practices
(n22 for intervention and n22 for control group) and 260 of their patients]40 years with obstructive lung diseases.
Results. Within the intervention group planned visits increased from 16% to 44% and from 19% to 25% in the control
condition (difference between groups p0.014). Annual lung function measurement rose from 17% to 67% in the
intervention and from 11% to 18% in the control group (difference between groups p0.001). Compared with control,
more but not statistically significant smokers received periodic advice to quit smoking (p0.16). At baseline 41% of the
intervention group were using their inhalers correctly and this increased to 54% after two years; it decreased in the control
group from 47 to 29% (difference between groups p0.002). The percentage of patients without exacerbation did not
change significantly compared with the control condition. The percentage of the intervention group not needing emergency
medication rose from 79% to 84% but decreased in the controls from 81 to 76% (difference between groups p0.08).
Conclusion. Combining different disciplines in one model has a positive effect on compliance with recommendations for
monitoring patients, and improves the care process and some patient outcomes.
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By far the majority of patients with COPD are
treated in general practice. To that end, international
and national guidelines have been developed [14].
Recommendations include using lung function mea-
surement in diagnostics and monitoring, checking
symptoms periodically and if necessary adjusting
medication, and educating patients to take respon-
sibility for the daily management of their disease.
However, care is often still not being given according
to the guidelines [5,6]. In particular lung function
measurements [7], periodic check-ups [8], and
supervision of inhalation techniques [9] have proved
to be difficult. To implement guidelines, care must
meet stringent requirements and should involve
various disciplines, from non-medical staff to med-
ical specialists. This means new disciplines are
needed in general practice and/or specific disciplines
outside general practice should be called in for task
delegation and consultation [10]. Various interven-
tions have been tested over the last few years. It
appears that a recall system can be successfully
organized on a scale that goes beyond the individual
general practice and can be run by someone without
a medical background [11]. Nurses can fulfil a key
role in clinics by providing patient education and
counselling [1215]. Delegation of medical tasks
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and the presence of a practice nurse are significant
associated with spirometry utilization [16]. A com-
bination of spirometry and smoking cessation advice
by a nurse appears to increase smoking cessation
rates in smokers with mild COPD [17]. According to
Bodenheimer et al. [18] the possibility of consulta-
tion with a specialist without a full referral con-
tributes fundamentally to the care of people with a
chronic disease.
We have developed a care model that fits into such
an approach to chronic disease management, one in
which various disciplines (general practitioner 
(GP), practice nurse, logistic COPD Support Ser-
vice (CSS) and chest physician (see Figure 1)) are
integrated. All these participating elements were
financed by the regular health insurance system.
The GP can delegate tasks to the nurse and the CSS.
The chest physician can support the diagnostic and
therapeutic decision-making without actually seeing
the patient. We assumed that the management of
chronic obstructive lung diseases could be improved
by the introduction of this model. The model was
focused on the]40 age group with chronic obstruc-
tive lung diseases covering asthma as well as COPD,
as the difference between COPD and asthma is not
always clearly established in the primary care popu-
lation. We performed a study to test the effects of the
care model for COPD and/or asthma on the process
of care and on patient outcomes.
Material and methods
Design and study population
The effect of the care model on COPD and/or
asthma was examined in a controlled study with
delayed intervention in the control group. With an
interval of two years, pre-test and post-test measure-
ments were performed. The care model was intro-
duced in a region in the south of the Netherlands in
2002 with a running-in period of over a year. During
that period the practice nurses were trained and the
CCS (a logistic support service, linked to the
regional primary care laboratory with a specialized
lung nurse and some administrative staff) was set
up. GPs qualified for a practice nurse if they had
working space for a nurse and an electronic patient
register. Due to limited funding, not all interested
practices could start at the same time. Based on
regional distribution criteria (division between sub-
regions and between urbanrural) the first cohort of
practices was selected to start with the care model in
2002. These practices formed the intervention group
(n22); the practices on the waiting list formed the
control group (n22). By October 2003, 11 prac-
tice nurses had been appointed. Before the nurse
started, a random sample of patients per practice was
drawn: patients]40 years with a documented lung
condition and using inhalation medicines (137 in the
intervention group and 123 in the control group).
Intervention
In each practice, the nurse (without knowing who
had been selected in the random sample) made a
survey of all patients]40 years with chronic lung
obstruction on the basis of diagnostic data and
medication use. The CSS called up all these patients
for extensive history-taking and lung function mea-
surement. The results were sent to a chest physician
for assessment, diagnosis (or confirming or adjusting
an earlier diagnosis), and advice on treatment. The
CSS maintained a register of patients qualifying for
annual history-taking and lung function measure-
ment. Patients visited their GP to discuss the resultsFigure 1. Actors primary care model COPD.
. To organize general practice care in a way
that planned care can be delivered to pa-
tients with chronic diseases, a number of
facilities are required which are often lacking
in usual care practices.
. For implementation of the national guide-
lines for the treatment of asthma and
COPD, the care has to meet stringent
requirements and should involve various
disciplines, ranging from non-medical staff
to medical specialists.
. Combining different disciplines in one in-
tegrated care model has a positive effect on
compliance with the recommendations
on monitoring patients, and improves the
process of care and some patient outcomes.
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and determine whether the medication was still
adequate. They also visited the practice nurse who
checked their inhalation technique, and gave educa-
tion and counselling (smoking cessation). Patients
who, according to the GP, met the criteria for
referral were referred to the chest physician.
In the control group the patients received the
usual care, which generally meant that they were
seen only when they consulted the GP about their
symptoms.
Variables and instruments
To study whether patients received care according to
the guidelines, we collected data on planned con-
sultations, periodic lung function measurements,
and smoking cessation advice. To measure the effect
of the care model on patient outcomes, we collected
data on smoking status, inhalation technique, ex-
acerbations, and emergency medication. Further-
more, some general characteristics from GPs and
patients were noted.
In more detail:
. Process of care: contact with the general prac-
tice (when symptoms deteriorated/or at fixed
moments); periodic lung function measure-
ments (no/yes, in the surgery/yes, by the labora-
tory); smoking cessation advice (yes/no).
. Smoking habits were assessed by asking patients
about current smoking behaviour (yes/no).
. The inhalation technique was checked with
inhalation-specific checklists from the Nether-
lands Asthma Foundation (Table I).
. Exacerbations were assessed by asking the
patient about the duration of symptoms or
changes in phlegm, cough, dyspnoea, wheezing,
and bronchodilator use in the past 3 months.
An exacerbation was defined as an episode
of3 days withthree of the above-mentioned
five items.
. Emergency medication: prescriptions for sys-
temic corticosteroids (Anatomic Therapeutic
Chemical Classification System (ATC) code
A07EA).
. General characteristics of the general practice:
number of GPs per location, degree of urbani-
zation (more or less than 80 000 inhabitants),
size of practice (number of registered patients),
number of active shifts per GP; number of
patients with documented asthma/COPD at
baseline, active recall system offering planned
care (yes/no).
. General characteristics of the patients: age,
gender. To assess the seriousness of the symp-
toms we used the MRC dyspnoea scale [19],
which comprises five statements: 1breathless
only on strenuous exercise; 2short of breath
when hurrying on the level or going up a slight
hill; 3walking slower than their peers on the
level because of breathlessness or having to
stop for breath when walking at own pace on
the level; 4stopping for breath after walking
100 metres or after a few minutes on the level;
5too breathless to leave the house.
All data were collected by means of questionnaires
completed by the GP and the patients [20], except
inhalation technique and emergency medication.
Inhalation technique was checked pre-test and
post-test by the same laboratory assistant. Data on
emergency medication were obtained from commu-
nity pharmacists.
Power calculation
As primary outcome variable we chose the correct
use by the patient of the inhaler because it has been
shown that change in organization of care integrating
non-physicians can influence this patient outcome
[21]. An earlier study showed that 60% of COPD
patients used their inhalers correctly [22]. With the
intervention, we expected an increase of 20%. Based
on an alpha of 5% and a beta of 80% a random
sample survey of 39 general practices with 5 patients
each was needed (195 patients), taking into account
clustering of patients per GP. With an expected
dropout of 10%, the total number of patients needed
was 215.
Analysis
Differences between the intervention and control
group were tested with mixed logic model repeated
measures (Glimmix procedure SAS V8.2). In all
tests, corrections were made for the random/cluster
effect caused by patient and GP.
Results
The 44 general practices approached were all
included; there were no dropouts. At baseline the
practices in the control group were comparable with
those in the intervention group regarding number of
GPs, population size, and average number of
asthma/COPD patients (Table II). None of the
practices had an active recall system offering planned
care to COPD and/or asthma patients. The inter-
vention practices were more often located in a city
(80 000 inhabitants) and were less often single-
handed than the controls.
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Data of 260 patients were collected at baseline.
The intervention group was comparable with the
controls regarding age, gender, and dyspnoea
score (Table II). During the intervention 94
patients (37% of the intervention and 36% of the
control group) dropped out (stopped inhalation
therapy, moved, died, were referred to a chest
physician, or no longer wanted to participate,
Figure 2), resulting in 87 in the intervention and
79 in the control group for the final measurement.
Analysis showed that patients who dropped out
did not differ in gender, age, and dyspnoea score
from patients who underwent a second measure-
ment. That is why we included all the patients in
the effect measurement (with more patients in the
pre-test than in the post-test).
Process of care
After two years of intervention, the percentage of
patients included in planned care at the general
practice rose from 16% to 44% (Table III). The
difference in change compared with the control
group is statistically significant. The percentage
undergoing periodical lung function measurements
rose from 17% to 67% (to 75% if only patients
involved in planned care are counted). All smokers
were periodically advised to quit.
Table I. Inhalation checklist.
Inhaler Inhaler with spacer Ingelheim inhaler
. Shake inhaler well and
remove protective cap
Hold inhaler with opening
underneath
. Breathe out
. Place mouthpiece
between teeth and seal lips
around it
. Push down top of inhaler
and breath in slowly and
deeply at the same time
Take inhaler out of the mouth
and hold breath to count of 510
Rinse mouth after using
corticosteroids
Clean inhaler 1a week
. Shake inhaler well and remove
protective cap
Put inhaler in spacer opening
. Put mask over nose and mouth
Place mouthpiece between teeth
and seal lips around it
. Press inhaler
. Breath in and out gently, adults
35 times, children and very breathless
patients 510 times, depending on the
volume of the spacer
Clean inhaler 1a week
Open mouthpiece
. Put capsule in the opening and
shut mouthpiece
. Hold inhaler with mouthpiece
at the top and press white
release button with thumb1
. Inhale
Turbuhaler Discus Diskhaler
Remove white protective cap
. Hold Turbuhaler upright
and twist blue or brown
base to the right
. Turn back until click
. Inhale
Put thumb on thumbgrip and push
your thumb away from you until
Discus clicks
. Slide lever away from you until
Discus clicks (just before use!)
. Inhale
Close Discus by turning thumbgrip
back (click)
The window indicates the remaining
number of inhalations
Remove cover
Pull the cartridge out using both hands
Push cartridge back in
. Raise lid as far as it will go to
pierce both sides
Close lid again
. Inhale
To replace medication disk press the
ridges on both sides and remove
cartridge. Replace medication disc
and slide cartridge back in
.essential in evaluation.
Table II. Characteristics of practices and patients (SD).
Intervention
group
Control
group
Characteristics of practices
Number of practices 22 22
Number of general practitioners 29 28
Urban practice (80 000
inhabitants) (%)
38 27
Single-handed practices (%) 27 52
Mean population/FTE 2519 (346) 2746 (414)
Mean number of asthma/COPD
patients/1000 patients1
47 (25) 51 (19)
Practices with active recall
system (%)
0 0
Characteristics of patients in sample
Number of patients 137 123
Mean age 59 (12) 58 (10)
Males (%) 42 48
Dyspnoea score 1 or 2 (%) 62 61
1Twelve intervention practices and 11 control practices could not
supply these data.
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Patient outcomes
The percentage of non-smokers rose 11% in the
intervention and 4% in the control group; the
difference in change was not statistically significant.
Regarding inhalation technique, the percentage of
patients handling their inhalers correctly rose from
41% to 54% in the intervention group while it
decreased in the control group from 47% to 29%.
The percentage of patients without exacerbation in
the previous three months rose from 79% to 81% in
the intervention group; it decreased in the controls
from 77% to 69%. The difference in change was not
statistically significant.
We also noticed a difference in change regarding
emergency medication. The percentage of patients
not needing emergency medication rose from 79% to
84% in the intervention group, while it decreased in
the control group; this difference was not statistically
significant.
Discussion
A model for integrated primary COPD and/or
asthma management was evaluated in this study.
The model proved to have a positive effect on plan-
ned care and periodic lung function measurement.
Figure 2. Patient flow.
Table III. Effect model on process of care and patient outcome.
Intervention Control Difference in change
between intervention and
control group Odds [CI] p-valueBefore After Before After
Process of care
Planned visits (% patients) 16 44 19 25 1.08 [1.2, 6.9] 0.014
Periodical lung function measurement
(% patients)
17 67 11 18 5.54 [1.9, 16.2] 0.001
Periodical smoking cessation advice
(% smokers)
60 100 61 58 17.41 [0.3, 971.4] 0.16
Patient outcome
Non-smokers (% patients) 70 81 70 74 1.03 [0.5, 1.8] 0.9
Correct inhalation technique (% patients) 41 54 47 29 3.68 [1.5, 8.5] 0.002
No exacerbation in 3 months (% patients) 79 81 77 69 1.75 [0.7, 5.0] 0.24
No emergency medication in 12 months
(% patients)
79 84 81 76 1.96 [0.8, 5.0] 0.08
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A positive effect on patient outcomes was also found.
The percentage of patients who used their inhalers
correctly rose, but the gain in preventing deteriora-
tion was even greater, as seen in the control group
where the inhalation technique was not checked
periodically (we hypothesized that if you assess
inhalation technique at a random moment in a
cross-sectional population, you also include people
who have recently started on medication and have
received instructions on how to use the inhaler and
have a good technique. If you follow that same
population, few people appear to retain the good
technique.) The data on patients in our study
correspond to those of another Dutch study GPs
(70% with a dyspnoea score52) [23]. At baseline we
found fewer patients with a correct inhalation tech-
nique than in a comparable study among a Dutch
population (45% vs. 72% with the correct technique).
The high score there may have been due to extra
attention to inhalation technique in a previous study
by the same researchers, as they suggest themselves
[24]. The difference between the intervention and
control group in our study may be substantial but still
half of all users do not handle their inhalers correctly,
meaning it is unclear whether they inhale the correct
dose of medication. Further studies are thus needed
to find out whether this can be improved by short-
ening the intervals between inhaler checks  for
example, a check at every prescription renewal,
because research shows that mistakes occur shortly
after the instructions are given, arguing in favour of
short cyclic check [25]. The treatment of acute
COPD exacerbations is shifting to general practi-
tioners [26]. Patient recognition of exacerbations and
prompt treatment improves exacerbation recovery,
reduces risks of hospitalization, and is associated with
a better health-related quality of life [27]. From this
perspective, the question is whether we should have
expected less or maybe even more emergency drug
use as positive effect of the care model. The decrease
we found is not significantly different from the control
group, but we believe it is a positive effect because we
also saw a decrease in self-reported exacerbations.
The number of patients willing to take part in the
study was relatively low (intervention: 68%, control
group: 65%) and the dropout rate was very high.
This can be considered a weakness of the study (for
data collection patients had to visit a laboratory
twice to check the inhalation technique and fill in the
questionnaire) but not a weakness of the care model.
In fact 88% of all patients being treated by the GP
were included in the care model [28].
Although the number of patients with both
measurements was lower than the calculated number
needed in the power analyses, we do not think
that our study is under-powered. In the repeated
measurement analysis (PROC MIXED, SAS) all
patients are included. This means that data on
patients with only one measurement were also
analysed. We did not study the cost-effectiveness of
the model, but we would like to make a few points
here. A great deal of the efforts (and thus also the
costs) in the intervention group were put into
surveying the target group. These efforts will always
be needed if the GP is going to provide planned
care for patients with asthma or COPD, and there-
fore should not be accounted to this specific model.
The same applies to setting up the call-up system.
On the other hand, paper consultations by chest
physicians are model-specific. Consultation in this
way is cheap, has proved to be valid [29], and
increases the number of patients who can be treated
in primary care.
We conclude that this study has shown that
combining various disciplines in an integrated model
as described here improves care processes and
patient outcomes in primary care for COPD and/or
asthma. The care model is especially interesting in
those settings in which chronic disease management
is general practice based.
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